{"id":130308,"date":"2026-05-28T08:42:00","date_gmt":"2026-05-28T11:42:00","guid":{"rendered":"https:\/\/bluestudio.estadao.com.br\/agencia-de-comunicacao\/prnewswire\/knight-se-apresentara-na-jefferies-2026-healthcare-conference-em-nova-york\/"},"modified":"2026-05-28T08:42:00","modified_gmt":"2026-05-28T11:42:00","slug":"knight-se-apresentara-na-jefferies-2026-healthcare-conference-em-nova-york","status":"publish","type":"post","link":"https:\/\/bluestudio.estadao.com.br\/agencia-de-comunicacao\/prnewswire\/knight-se-apresentara-na-jefferies-2026-healthcare-conference-em-nova-york\/","title":{"rendered":"Knight se apresentar\u00e1 na Jefferies 2026 Healthcare Conference em Nova York"},"content":{"rendered":"\n
\nMONTREAL<\/span>, 28 de maio de 2026<\/span> \/PRNewswire\/ — Knight Therapeutics Inc. (TSX: GUD) (“Knight”) uma empresa farmac\u00eautica l\u00edder no mercado pan-americana (ex-EUA), anunciou hoje que Samira Sakhia, presidente e diretora executiva, est\u00e1 programada para apresentar na Jefferies 2026 Healthcare Conference<\/b> na quinta-feira, 4 de junho de 2026 \u00e0s 2:35 PM ET na cidade de Nova York. Uma c\u00f3pia da apresenta\u00e7\u00e3o estar\u00e1 dispon\u00edvel em www.knighttx.com<\/a>.<\/p>\n
\n \"Knight<\/a>\n <\/p>\n<\/p><\/div>\n

Sobre a Knight Therapeutics Inc.<\/b><\/p>\n

A Knight Therapeutics Inc., com sede em Montreal, Canad\u00e1, \u00e9 uma empresa farmac\u00eautica com foco na aquisi\u00e7\u00e3o ou licenciamento e comercializa\u00e7\u00e3o de produtos farmac\u00eauticos para o Canad\u00e1 e a Am\u00e9rica Latina. As subsidi\u00e1rias latino-americanas da Knight operam sob os nomes United Medical, Biotoscana Farma e Laboratorio LKM. As a\u00e7\u00f5es da Knight Therapeutics Inc. s\u00e3o negociadas na TSX sob o s\u00edmbolo GUD. Para obter mais informa\u00e7\u00f5es sobre a Knight Therapeutics Inc., visite o site da empresa em www.knighttx.com<\/a> ou www.sedarplus.ca<\/a>. <\/p>\n

Declara\u00e7\u00e3o de vis\u00e3o<\/b><\/p>\n

Este documento cont\u00e9m declara\u00e7\u00f5es relativas ao futuro em rela\u00e7\u00e3o a Knight Therapeutics Inc. e suas subsidi\u00e1rias. Essas declara\u00e7\u00f5es relativas ao futuro, por sua natureza, envolvem necessariamente riscos e incertezas que podem fazer com que os resultados reais sejam materialmente diferentes daqueles contemplados nas declara\u00e7\u00f5es prospectivas. A Knight Therapeutics Inc. considera as suposi\u00e7\u00f5es nas quais essas declara\u00e7\u00f5es relativas ao futuro se baseiam como razo\u00e1veis no momento em que foram preparadas, mas adverte o leitor de que essas suposi\u00e7\u00f5es sobre eventos futuros, muitos dos quais est\u00e3o al\u00e9m do controle da Knight Therapeutics Inc. e de suas subsidi\u00e1rias, podem acabar sendo incorretas. Fatores e riscos que podem fazer com que os resultados reais difiram materialmente das expectativas atuais s\u00e3o discutidos no Relat\u00f3rio Anual da Knight Therapeutics Inc. e no Formul\u00e1rio de Informa\u00e7\u00f5es Anuais da Knight Therapeutics Inc. para o ano encerrado em 31 de dezembro de 2025, arquivado em www.sedarplus.ca<\/a>. A Knight Therapeutics Inc. nega qualquer inten\u00e7\u00e3o ou obriga\u00e7\u00e3o de atualizar ou revisar quaisquer declara\u00e7\u00f5es relativas ao futuro devido a novas informa\u00e7\u00f5es ou eventos futuros, exceto conforme seja exigido por lei.<\/p>\n

\n\n\n\n\n\n\n\n\n
\n

Contato de investidores:<\/b><\/span><\/p>\n<\/td>\n

<\/td>\n<\/td>\n<\/tr>\n
\n

Knight Therapeutics Inc.<\/span><\/p>\n<\/td>\n

<\/td>\n<\/td>\n<\/tr>\n
\n

Samira Sakhia<\/span><\/p>\n<\/td>\n

<\/td>\n\n

Arvind Utchanah<\/span><\/p>\n<\/td>\n<\/tr>\n

\n

Presidente e Diretora Executiva<\/span><\/p>\n<\/td>\n

<\/td>\n\n

Diretor Financeiro<\/span><\/p>\n<\/td>\n<\/tr>\n

\n

Tel.: 514.484.4483 <\/span><\/p>\n<\/td>\n

<\/td>\n\n

Tel.: 514-484-4483<\/span><\/p>\n<\/td>\n<\/tr>\n

\n

Email: IR@knighttx.com<\/a><\/span><\/p>\n<\/td>\n

<\/td>\n\n

Email: IR@knighttx.com<\/a><\/span><\/p>\n<\/td>\n<\/tr>\n

\n

Website: www.knighttx.com<\/a><\/span><\/p>\n<\/td>\n

<\/td>\n\n

Website: www.knighttx.com<\/a><\/span><\/p>\n<\/td>\n<\/tr>\n<\/table>\n<\/div>\n

Logo – https:\/\/mma.prnewswire.com\/media\/2988255\/Knight_Therapeutics_Logo.jpg<\/a> <\/p>\n

\"Cision\" View original content to download multimedia:https:\/\/www.prnewswire.com\/br\/comunicados-para-a-imprensa\/knight-se-apresentara-na-jefferies-2026-healthcare-conference-em-nova-york-302782344.html<\/a><\/p>\n

FONTE Knight Therapeutics Inc.<\/p>\n<\/div>\n

\"\"<\/p>\n

T\u00f3picos Relacionados:<\/strong> Produtos Farmac\u00eauticos, M\u00e9dico \/ Farmac\u00eautico, Not\u00edcias de Feiras Comerciais, Eventos Futuros, Sa\u00fade\/Hospitais<\/p>\n

A OESP<\/b> n\u00e3o \u00e9(s\u00e3o) respons\u00e1vel(is) por erros, incorre\u00e7\u00f5es, atrasos ou quaisquer decis\u00f5es tomadas por seus clientes com base nos Conte\u00fados ora disponibilizados, bem como tais Conte\u00fados n\u00e3o representam a opini\u00e3o da OESP<\/b> e s\u00e3o de inteira responsabilidade da PR Newswire Ltda<\/b><\/p>\n","protected":false},"excerpt":{"rendered":"MONTREAL, 28 de maio de 2026 \/PRNewswire\/ — Knight Therapeutics Inc. (TSX: GUD) (“Knight”) uma empresa farmac\u00eautica l\u00edder no mercado pan-americana (ex-EUA), anunciou hoje que","protected":false},"author":1,"featured_media":130309,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"inline_featured_image":false,"_monsterinsights_skip_tracking":false,"footnotes":""},"categories":[27],"tags":[9609,10087,9610],"class_list":["post-130308","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-prnewswire","tag-anunciou-hoje-que-samira-sakhia","tag-knight-therapeutics-inc-tsx-gud-knight-uma-empresa-farmaceutica-lider-no-mercado-pan-americana-ex-eua","tag-presidente-e-diretora-executiva"],"acf":[],"yoast_head":"\nKnight se apresentar\u00e1 na Jefferies 2026 Healthcare Conference em Nova York - Ag\u00eancia de Comunica\u00e7\u00e3o<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/bluestudio.estadao.com.br\/agencia-de-comunicacao\/prnewswire\/knight-se-apresentara-na-jefferies-2026-healthcare-conference-em-nova-york\/\" \/>\n<meta property=\"og:locale\" content=\"pt_BR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Knight se apresentar\u00e1 na Jefferies 2026 Healthcare Conference em Nova York - Ag\u00eancia de Comunica\u00e7\u00e3o\" \/>\n<meta property=\"og:description\" content=\"MONTREAL, 28 de maio de 2026 \/PRNewswire\/ — Knight Therapeutics Inc. (TSX: GUD) (“Knight”) uma empresa farmac\u00eautica l\u00edder no mercado pan-americana (ex-EUA), anunciou hoje que\" \/>\n<meta property=\"og:url\" content=\"https:\/\/bluestudio.estadao.com.br\/agencia-de-comunicacao\/prnewswire\/knight-se-apresentara-na-jefferies-2026-healthcare-conference-em-nova-york\/\" \/>\n<meta property=\"og:site_name\" content=\"Ag\u00eancia de Comunica\u00e7\u00e3o\" \/>\n<meta property=\"article:published_time\" content=\"2026-05-28T11:42:00+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/bluestudio.estadao.com.br\/agencia-de-comunicacao\/wp-content\/uploads\/2026\/05\/1_53_2_2026-05-28_7.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1\" \/>\n\t<meta property=\"og:image:height\" content=\"1\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"patric_oliveira\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Escrito por\" \/>\n\t<meta name=\"twitter:data1\" content=\"patric_oliveira\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. tempo de leitura\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/bluestudio.estadao.com.br\\\/agencia-de-comunicacao\\\/prnewswire\\\/knight-se-apresentara-na-jefferies-2026-healthcare-conference-em-nova-york\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/bluestudio.estadao.com.br\\\/agencia-de-comunicacao\\\/prnewswire\\\/knight-se-apresentara-na-jefferies-2026-healthcare-conference-em-nova-york\\\/\"},\"author\":{\"name\":\"patric_oliveira\",\"@id\":\"https:\\\/\\\/bluestudio.estadao.com.br\\\/agencia-de-comunicacao\\\/#\\\/schema\\\/person\\\/3565da46092a837cdffa42904dfc6d37\"},\"headline\":\"Knight se apresentar\u00e1 na Jefferies 2026 Healthcare Conference em Nova York\",\"datePublished\":\"2026-05-28T11:42:00+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/bluestudio.estadao.com.br\\\/agencia-de-comunicacao\\\/prnewswire\\\/knight-se-apresentara-na-jefferies-2026-healthcare-conference-em-nova-york\\\/\"},\"wordCount\":514,\"commentCount\":0,\"image\":{\"@id\":\"https:\\\/\\\/bluestudio.estadao.com.br\\\/agencia-de-comunicacao\\\/prnewswire\\\/knight-se-apresentara-na-jefferies-2026-healthcare-conference-em-nova-york\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/bluestudio.estadao.com.br\\\/agencia-de-comunicacao\\\/wp-content\\\/uploads\\\/2026\\\/05\\\/1_53_2_2026-05-28_7.jpg\",\"keywords\":[\"anunciou hoje que Samira Sakhia\",\"Knight Therapeutics Inc. (TSX: GUD) (\\\"Knight\\\") uma empresa farmac\u00eautica l\u00edder no mercado pan-americana (ex-EUA)\",\"presidente e diretora executiva\"],\"articleSection\":[\"PR Newswire\"],\"inLanguage\":\"pt-BR\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/bluestudio.estadao.com.br\\\/agencia-de-comunicacao\\\/prnewswire\\\/knight-se-apresentara-na-jefferies-2026-healthcare-conference-em-nova-york\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/bluestudio.estadao.com.br\\\/agencia-de-comunicacao\\\/prnewswire\\\/knight-se-apresentara-na-jefferies-2026-healthcare-conference-em-nova-york\\\/\",\"url\":\"https:\\\/\\\/bluestudio.estadao.com.br\\\/agencia-de-comunicacao\\\/prnewswire\\\/knight-se-apresentara-na-jefferies-2026-healthcare-conference-em-nova-york\\\/\",\"name\":\"Knight se apresentar\u00e1 na Jefferies 2026 Healthcare Conference em Nova York - Ag\u00eancia de Comunica\u00e7\u00e3o\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/bluestudio.estadao.com.br\\\/agencia-de-comunicacao\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/bluestudio.estadao.com.br\\\/agencia-de-comunicacao\\\/prnewswire\\\/knight-se-apresentara-na-jefferies-2026-healthcare-conference-em-nova-york\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/bluestudio.estadao.com.br\\\/agencia-de-comunicacao\\\/prnewswire\\\/knight-se-apresentara-na-jefferies-2026-healthcare-conference-em-nova-york\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/bluestudio.estadao.com.br\\\/agencia-de-comunicacao\\\/wp-content\\\/uploads\\\/2026\\\/05\\\/1_53_2_2026-05-28_7.jpg\",\"datePublished\":\"2026-05-28T11:42:00+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/bluestudio.estadao.com.br\\\/agencia-de-comunicacao\\\/#\\\/schema\\\/person\\\/3565da46092a837cdffa42904dfc6d37\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/bluestudio.estadao.com.br\\\/agencia-de-comunicacao\\\/prnewswire\\\/knight-se-apresentara-na-jefferies-2026-healthcare-conference-em-nova-york\\\/#breadcrumb\"},\"inLanguage\":\"pt-BR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/bluestudio.estadao.com.br\\\/agencia-de-comunicacao\\\/prnewswire\\\/knight-se-apresentara-na-jefferies-2026-healthcare-conference-em-nova-york\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"pt-BR\",\"@id\":\"https:\\\/\\\/bluestudio.estadao.com.br\\\/agencia-de-comunicacao\\\/prnewswire\\\/knight-se-apresentara-na-jefferies-2026-healthcare-conference-em-nova-york\\\/#primaryimage\",\"url\":\"https:\\\/\\\/bluestudio.estadao.com.br\\\/agencia-de-comunicacao\\\/wp-content\\\/uploads\\\/2026\\\/05\\\/1_53_2_2026-05-28_7.jpg\",\"contentUrl\":\"https:\\\/\\\/bluestudio.estadao.com.br\\\/agencia-de-comunicacao\\\/wp-content\\\/uploads\\\/2026\\\/05\\\/1_53_2_2026-05-28_7.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/bluestudio.estadao.com.br\\\/agencia-de-comunicacao\\\/prnewswire\\\/knight-se-apresentara-na-jefferies-2026-healthcare-conference-em-nova-york\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"In\u00edcio\",\"item\":\"https:\\\/\\\/bluestudio.estadao.com.br\\\/agencia-de-comunicacao\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Knight se apresentar\u00e1 na Jefferies 2026 Healthcare Conference em Nova York\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/bluestudio.estadao.com.br\\\/agencia-de-comunicacao\\\/#website\",\"url\":\"https:\\\/\\\/bluestudio.estadao.com.br\\\/agencia-de-comunicacao\\\/\",\"name\":\"Ag\u00eancia de Comunica\u00e7\u00e3o\",\"description\":\"Conte\u00fado estrat\u00e9gico para engajar seu p\u00fablico com a expertise do Estad\u00e3o.\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/bluestudio.estadao.com.br\\\/agencia-de-comunicacao\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"pt-BR\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/bluestudio.estadao.com.br\\\/agencia-de-comunicacao\\\/#\\\/schema\\\/person\\\/3565da46092a837cdffa42904dfc6d37\",\"name\":\"patric_oliveira\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"pt-BR\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/0ca7e6312c4efc0dd6566e6d38573727fdf4333d14aff8583ce79423883088a1?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/0ca7e6312c4efc0dd6566e6d38573727fdf4333d14aff8583ce79423883088a1?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/0ca7e6312c4efc0dd6566e6d38573727fdf4333d14aff8583ce79423883088a1?s=96&d=mm&r=g\",\"caption\":\"patric_oliveira\"},\"sameAs\":[\"https:\\\/\\\/bluestudio.estadao.com.br\\\/agencia-de-comunicacao\\\/\"],\"url\":\"https:\\\/\\\/bluestudio.estadao.com.br\\\/agencia-de-comunicacao\\\/author\\\/patric_oliveira\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Knight se apresentar\u00e1 na Jefferies 2026 Healthcare Conference em Nova York - Ag\u00eancia de Comunica\u00e7\u00e3o","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/bluestudio.estadao.com.br\/agencia-de-comunicacao\/prnewswire\/knight-se-apresentara-na-jefferies-2026-healthcare-conference-em-nova-york\/","og_locale":"pt_BR","og_type":"article","og_title":"Knight se apresentar\u00e1 na Jefferies 2026 Healthcare Conference em Nova York - Ag\u00eancia de Comunica\u00e7\u00e3o","og_description":"MONTREAL, 28 de maio de 2026 \/PRNewswire\/ — Knight Therapeutics Inc. (TSX: GUD) (“Knight”) uma empresa farmac\u00eautica l\u00edder no mercado pan-americana (ex-EUA), anunciou hoje que","og_url":"https:\/\/bluestudio.estadao.com.br\/agencia-de-comunicacao\/prnewswire\/knight-se-apresentara-na-jefferies-2026-healthcare-conference-em-nova-york\/","og_site_name":"Ag\u00eancia de Comunica\u00e7\u00e3o","article_published_time":"2026-05-28T11:42:00+00:00","og_image":[{"url":"https:\/\/bluestudio.estadao.com.br\/agencia-de-comunicacao\/wp-content\/uploads\/2026\/05\/1_53_2_2026-05-28_7.jpg","width":1,"height":1,"type":"image\/jpeg"}],"author":"patric_oliveira","twitter_card":"summary_large_image","twitter_misc":{"Escrito por":"patric_oliveira","Est. tempo de leitura":"2 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/bluestudio.estadao.com.br\/agencia-de-comunicacao\/prnewswire\/knight-se-apresentara-na-jefferies-2026-healthcare-conference-em-nova-york\/#article","isPartOf":{"@id":"https:\/\/bluestudio.estadao.com.br\/agencia-de-comunicacao\/prnewswire\/knight-se-apresentara-na-jefferies-2026-healthcare-conference-em-nova-york\/"},"author":{"name":"patric_oliveira","@id":"https:\/\/bluestudio.estadao.com.br\/agencia-de-comunicacao\/#\/schema\/person\/3565da46092a837cdffa42904dfc6d37"},"headline":"Knight se apresentar\u00e1 na Jefferies 2026 Healthcare Conference em Nova York","datePublished":"2026-05-28T11:42:00+00:00","mainEntityOfPage":{"@id":"https:\/\/bluestudio.estadao.com.br\/agencia-de-comunicacao\/prnewswire\/knight-se-apresentara-na-jefferies-2026-healthcare-conference-em-nova-york\/"},"wordCount":514,"commentCount":0,"image":{"@id":"https:\/\/bluestudio.estadao.com.br\/agencia-de-comunicacao\/prnewswire\/knight-se-apresentara-na-jefferies-2026-healthcare-conference-em-nova-york\/#primaryimage"},"thumbnailUrl":"https:\/\/bluestudio.estadao.com.br\/agencia-de-comunicacao\/wp-content\/uploads\/2026\/05\/1_53_2_2026-05-28_7.jpg","keywords":["anunciou hoje que Samira Sakhia","Knight Therapeutics Inc. (TSX: GUD) (\"Knight\") uma empresa farmac\u00eautica l\u00edder no mercado pan-americana (ex-EUA)","presidente e diretora executiva"],"articleSection":["PR Newswire"],"inLanguage":"pt-BR","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/bluestudio.estadao.com.br\/agencia-de-comunicacao\/prnewswire\/knight-se-apresentara-na-jefferies-2026-healthcare-conference-em-nova-york\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/bluestudio.estadao.com.br\/agencia-de-comunicacao\/prnewswire\/knight-se-apresentara-na-jefferies-2026-healthcare-conference-em-nova-york\/","url":"https:\/\/bluestudio.estadao.com.br\/agencia-de-comunicacao\/prnewswire\/knight-se-apresentara-na-jefferies-2026-healthcare-conference-em-nova-york\/","name":"Knight se apresentar\u00e1 na Jefferies 2026 Healthcare Conference em Nova York - Ag\u00eancia de Comunica\u00e7\u00e3o","isPartOf":{"@id":"https:\/\/bluestudio.estadao.com.br\/agencia-de-comunicacao\/#website"},"primaryImageOfPage":{"@id":"https:\/\/bluestudio.estadao.com.br\/agencia-de-comunicacao\/prnewswire\/knight-se-apresentara-na-jefferies-2026-healthcare-conference-em-nova-york\/#primaryimage"},"image":{"@id":"https:\/\/bluestudio.estadao.com.br\/agencia-de-comunicacao\/prnewswire\/knight-se-apresentara-na-jefferies-2026-healthcare-conference-em-nova-york\/#primaryimage"},"thumbnailUrl":"https:\/\/bluestudio.estadao.com.br\/agencia-de-comunicacao\/wp-content\/uploads\/2026\/05\/1_53_2_2026-05-28_7.jpg","datePublished":"2026-05-28T11:42:00+00:00","author":{"@id":"https:\/\/bluestudio.estadao.com.br\/agencia-de-comunicacao\/#\/schema\/person\/3565da46092a837cdffa42904dfc6d37"},"breadcrumb":{"@id":"https:\/\/bluestudio.estadao.com.br\/agencia-de-comunicacao\/prnewswire\/knight-se-apresentara-na-jefferies-2026-healthcare-conference-em-nova-york\/#breadcrumb"},"inLanguage":"pt-BR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/bluestudio.estadao.com.br\/agencia-de-comunicacao\/prnewswire\/knight-se-apresentara-na-jefferies-2026-healthcare-conference-em-nova-york\/"]}]},{"@type":"ImageObject","inLanguage":"pt-BR","@id":"https:\/\/bluestudio.estadao.com.br\/agencia-de-comunicacao\/prnewswire\/knight-se-apresentara-na-jefferies-2026-healthcare-conference-em-nova-york\/#primaryimage","url":"https:\/\/bluestudio.estadao.com.br\/agencia-de-comunicacao\/wp-content\/uploads\/2026\/05\/1_53_2_2026-05-28_7.jpg","contentUrl":"https:\/\/bluestudio.estadao.com.br\/agencia-de-comunicacao\/wp-content\/uploads\/2026\/05\/1_53_2_2026-05-28_7.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/bluestudio.estadao.com.br\/agencia-de-comunicacao\/prnewswire\/knight-se-apresentara-na-jefferies-2026-healthcare-conference-em-nova-york\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"In\u00edcio","item":"https:\/\/bluestudio.estadao.com.br\/agencia-de-comunicacao\/"},{"@type":"ListItem","position":2,"name":"Knight se apresentar\u00e1 na Jefferies 2026 Healthcare Conference em Nova York"}]},{"@type":"WebSite","@id":"https:\/\/bluestudio.estadao.com.br\/agencia-de-comunicacao\/#website","url":"https:\/\/bluestudio.estadao.com.br\/agencia-de-comunicacao\/","name":"Ag\u00eancia de Comunica\u00e7\u00e3o","description":"Conte\u00fado estrat\u00e9gico para engajar seu p\u00fablico com a expertise do Estad\u00e3o.","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/bluestudio.estadao.com.br\/agencia-de-comunicacao\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"pt-BR"},{"@type":"Person","@id":"https:\/\/bluestudio.estadao.com.br\/agencia-de-comunicacao\/#\/schema\/person\/3565da46092a837cdffa42904dfc6d37","name":"patric_oliveira","image":{"@type":"ImageObject","inLanguage":"pt-BR","@id":"https:\/\/secure.gravatar.com\/avatar\/0ca7e6312c4efc0dd6566e6d38573727fdf4333d14aff8583ce79423883088a1?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/0ca7e6312c4efc0dd6566e6d38573727fdf4333d14aff8583ce79423883088a1?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/0ca7e6312c4efc0dd6566e6d38573727fdf4333d14aff8583ce79423883088a1?s=96&d=mm&r=g","caption":"patric_oliveira"},"sameAs":["https:\/\/bluestudio.estadao.com.br\/agencia-de-comunicacao\/"],"url":"https:\/\/bluestudio.estadao.com.br\/agencia-de-comunicacao\/author\/patric_oliveira\/"}]}},"_links":{"self":[{"href":"https:\/\/bluestudio.estadao.com.br\/agencia-de-comunicacao\/wp-json\/wp\/v2\/posts\/130308","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/bluestudio.estadao.com.br\/agencia-de-comunicacao\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/bluestudio.estadao.com.br\/agencia-de-comunicacao\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/bluestudio.estadao.com.br\/agencia-de-comunicacao\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/bluestudio.estadao.com.br\/agencia-de-comunicacao\/wp-json\/wp\/v2\/comments?post=130308"}],"version-history":[{"count":0,"href":"https:\/\/bluestudio.estadao.com.br\/agencia-de-comunicacao\/wp-json\/wp\/v2\/posts\/130308\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/bluestudio.estadao.com.br\/agencia-de-comunicacao\/wp-json\/wp\/v2\/media\/130309"}],"wp:attachment":[{"href":"https:\/\/bluestudio.estadao.com.br\/agencia-de-comunicacao\/wp-json\/wp\/v2\/media?parent=130308"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/bluestudio.estadao.com.br\/agencia-de-comunicacao\/wp-json\/wp\/v2\/categories?post=130308"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/bluestudio.estadao.com.br\/agencia-de-comunicacao\/wp-json\/wp\/v2\/tags?post=130308"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}